Log In
BCIQ
Print this Print this
 

Mul-1867

  Manage Alerts
Collapse Summary General Information
Company TGV-Laboratories Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat antibiotic-resistant bacterial lung infections in patients with cystic fibrosis
Regulatory Designation U.S. - Orphan Drug (Treat antibiotic-resistant bacterial lung infections in patients with cystic fibrosis)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today